Delivery Order SPE2DB20D1100-SPE2DB25FA0N5
Award Date
1/14/25
Potential Completion Date
1/15/25
Potential Value
$14K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $12,913.51 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. for the supply of Dupixent 300 mg/2 ml pens. The contract has an ultimate completion date of February 25, 2025. AmerisourceBergen is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies. The company holds a significant $999,999,999 Indefinite Delivery...
This is a $25,097.18 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Dupixent 300 mg/2 ml pens and has a completion date of March 6, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract with DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $24,975.24, is for the delivery of Dupixent 300 mg/2 ml pens. The contract has an ultimate completion date of May 28, 2024. AmerisourceBergen is not designated as a set-aside vendor for this contract. The company also holds a $999,999,999 Indefinite Delivery Contract (IDC)...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,261.75 firm fixed-price delivery order contract is for the supply of Dupixent 300 mg/2 ml pens, a specialty pharmaceutical product. The contract has an ultimate completion date of November 24, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This is a $35,405.63 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Dupixent 300 mg/2 ml pens and has a June 2024 completion date. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a broad range of pharmaceutical products and medical supplies to support military healthcare...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $18,493.84, is a Delivery Order for the supply of Dupixent 300 mg/2 ml pens. The contract has an ultimate completion date of July 29, 2024 and is a Firm Fixed Price arrangement. Amerisourcebergen Drug Corp is the prime contractor, and there is no indication of any set-aside designation for this...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $27,491.50, is a Firm Fixed Price Delivery Order to supply Dupixent 300 mg/2 ml pens. The contract has an ultimate completion date of December 3, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,529.78, is for the delivery of Dupixent 300 mg/2 ml pens. It is a firm-fixed-price delivery order with a completion date of November 24, 2023. The contract is not associated with a set-aside program. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a wholly-owned subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical company. The $15,490.47 firm fixed price delivery order is for the supply of Dupixent 300 mg/2 ml pens. The contract has an ultimate completion date of April 8, 2024. This order is part of a broader indefinite delivery contract (IDC) valued at up to $999,999,999.00 that was awarded solely to...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $38,086.15, is for the delivery of Dupixent 300 mg/2 ml pens. This is a firm fixed-price delivery order contract with an ultimate completion date of July 17, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support...